Today: 9 July 2026
Browse Category

Earnings Reports 6 May 2026 - 7 May 2026

Why Himax Technologies Stock Is Surging: Q2 Guidance, Dividend and AI Glasses Bets

Why Himax Technologies Stock Is Surging: Q2 Guidance, Dividend and AI Glasses Bets

Himax Technologies surged over 30% in U.S. trading on Thursday, with the Taiwan-based display-chip company projecting a second-quarter comeback and announcing a cash dividend. The update threw fresh attention on its automotive display and low-power AI segments. Nasdaq-listed shares were last seen at $16.17, up $3.84, after spiking to $17.94 earlier in the session.
Howmet Aerospace Stock Jumps: HWM Raises 2026 Forecast as Jet Demand Powers Profit Beat

Howmet Aerospace Stock Jumps: HWM Raises 2026 Forecast as Jet Demand Powers Profit Beat

Shares of Howmet Aerospace shot higher Thursday as the Pittsburgh-based aircraft-parts supplier topped Wall Street’s first-quarter forecasts and raised its guidance for 2026, citing robust orders from commercial aerospace, defense, and gas turbine segments. Quarterly revenue jumped 19% to $2.31 billion, with adjusted EPS up 42% to $1.22.
Celsius Stock Rallies After Earnings Beat as Alani Nu and Rockstar Lift Sales

Celsius Stock Rallies After Earnings Beat as Alani Nu and Rockstar Lift Sales

Celsius Holdings soared Thursday, popping up to 10% before the bell after the company posted first-quarter numbers that topped Street forecasts. The energy-drink player delivered $782.6 million in revenue—well ahead of the $764.4 million analysts had penciled in—and reported adjusted earnings per share above estimates. Sales growth was fueled in part by Alani Nu and Rockstar Energy as Celsius made further inroads in U.S. energy drinks.
Fortinet Stock Surges 12% as Q1 Beat and 2026 Guidance Put AI Security Demand Back in Focus

Fortinet Stock Surges 12% as Q1 Beat and 2026 Guidance Put AI Security Demand Back in Focus

Fortinet jumped 12.3% ahead of the bell Thursday, after the cybersecurity name came through with first-quarter numbers that beat Wall Street, and dialed up its 2026 forecast on stronger demand for network-security offerings. Adjusted earnings landed at 82 cents per share on $1.85 billion in revenue, topping consensus calls for 62 cents and $1.73 billion.
Primerica Q1 Earnings Beat Wall Street, But A Life Insurance Slowdown Is Hiding In The Numbers

Primerica Q1 Earnings Beat Wall Street, But A Life Insurance Slowdown Is Hiding In The Numbers

Primerica Inc. topped analyst expectations for both profit and revenue in the first quarter, reporting after the bell on Wednesday. Surging sales of investment products offset a slowdown in new term life insurance. Adjusted operating earnings landed at $5.96 per share, with adjusted operating revenue hitting $872.3 million. That’s ahead of the $5.48 per share and $856.4 million in revenue analysts surveyed by StockStory had forecast.
Why Redwire Stock Fell After a Record Backlog: Q1 Miss and $350 Million Share Sale Plan

Why Redwire Stock Fell After a Record Backlog: Q1 Miss and $350 Million Share Sale Plan

Redwire Corporation stock slid in after-hours trading Wednesday, as the space infrastructure firm fell short of analysts’ forecasts on both revenue and earnings. Not even a record-high order backlog or stronger gross margins could offset the disappointment. The company also moved to register up to $350 million in common stock for possible sale, raising dilution concerns among investors.
Coherent Stock Falls After AI-Fueled Q3 Beat: Why Wall Street Still Sold COHR

Coherent Stock Falls After AI-Fueled Q3 Beat: Why Wall Street Still Sold COHR

Coherent Corp. dropped roughly 6% after hours Wednesday, despite the photonics supplier beating fiscal third-quarter revenue expectations and projecting results above what Wall Street had penciled in—a clear sign investors were looking for more from a name riding this year’s AI-infrastructure boom. Revenue came in at $1.81 billion, marking a 20.5% jump from the prior year, with adjusted earnings at $1.41 a share.
1 18 19 20 21 22 262

Stock Market Today

  • Virax Biolabs Signs Exclusive Supply Pact With Fosun Diagnostics for Southeast Asia
    July 9, 2026, 8:49 AM EDT. Virax Biolabs Group Limited (NASDAQ: VRAX) has landed an exclusive commercial supply deal with Fosun Diagnostics to cover six Southeast Asian countries: Thailand, Vietnam, Indonesia, the Philippines, Singapore, and Malaysia. The agreement is for Virax's ImmuneSelect immune profiling products, separate from its diagnostic platform that's still in the works. Virax can now supply products right away through purchase orders, eyeing near-term revenue and a wider regional presence. Fosun Diagnostics, under Fosun Pharma, will use its network for distribution across the region. The agreement leaves room for more products, higher volume, and the chance of OEM or private-label deals down the line. Pricing is set up for scale. The deal moves Virax further into the ASEAN diagnostics market.
Go toTop